Covid-19 | Subscribe

Pharmacovigilance Inspections for Human Medicinal Products

Home >  Pharmacovigilance Inspections for Human Medicinal Products

06 May

Posted at 16:23h in

This document has been prepared to serve as a guideline to those involved in the conduct of Pharmacovigilance inspections. It is meant to facilitate compliance with Good Pharmacovigilance Practice relating to the conduct and monitoring of Pharmacovigilance inspections. It is not intended as an exclusive...

27 Apr

Posted at 16:43h in

This guideline is intended to provide guidance to applicants wishing to submit an appeal against all regulatory decisions that are administrative in nature.   Any person aggrieved by the decision of the Authority may appeal against such decision by notifying the Chief Executive Officer within thirty (30)...

21 Apr

Posted at 09:41h in

The aim of this newsletter is to disseminate regulatory information on post-marketing surveillance and pharmacovigilance activities rendered by SAHPRA, which includes responsibilities of the SAHPRA Pharmacovigilance unit, reporting tools and pharmacovigilance systems in the country....

14 Apr

Posted at 10:18h in

This guideline is intended to provide guidance to applicants wishing to submit new application for registration of biological medicines. It represents the Authority’s current thinking on the safety, efficacy and quality of medicines. It is not intended as an exclusive approach. SAHPRA reserves the right...

01 Apr

Posted at 14:17h in

On the 5th of March 2020, Minister of Health Zweli Mkhize confirmed the spread of the virus to South Africa, with the first known patient being a male citizen who tested positive upon his return from Italy. The vast range of self-testing kits as well...